Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.915
+0.075 (2.64%)
Feb 11, 2026, 10:59 AM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 230.74 million as of February 10, 2026. Its market cap has decreased by -37.58% in one year.
Market Cap
230.74M
Enterprise Value
171.61M
Revenue
408.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.92
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 230.74M, an increase of 405.35%. That is a compound annual growth rate of 9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 229.11M | -9.32% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.01B |
| Pro Medicus | 16.47B |
| Cochlear | 16.36B |
| Sonic Healthcare | 10.88B |
| Monash IVF Group | 266.90M |
| Orthocell | 246.89M |
| Botanix Pharmaceuticals | 236.41M |
| Aroa Biosurgery | 224.56M |